{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:21:15Z","timestamp":1769944875316,"version":"3.49.0"},"reference-count":146,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Spinocerebellar ataxia type 3 (SCA3) is the most common type of spinocerebellar ataxia, which are inherited neurodegenerative diseases. CAG repeat expansions that translate into an abnormal length of glutamine residues are considered to be the disease-causing mutation. The pathological mechanisms of SCA3 are not fully elucidated but may include aggregate or inclusion formation, imbalance of cellular protein homeostasis, axonal transportation dysfunction, translation dysregulation, mitochondrial damage and oxidative stress, abnormal neural signaling pathways, etc. Currently, symptom relief is the only available therapeutic route; however, promising therapeutic targets have been discovered, such as decreasing the mutant protein through RNA interference (RNAi) and antisense oligonucleotides (AONs) and replacement therapy using stem cell transplantation. Other potential targets can inhibit the previously mentioned pathological mechanisms. However, additional efforts are necessary before these strategies can be used clinically.<\/jats:p>","DOI":"10.1515\/revneuro-2014-0040","type":"journal-article","created":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T17:40:57Z","timestamp":1410543657000},"source":"Crossref","is-referenced-by-count":10,"title":["An insight into advances in the pathogenesis and therapeutic strategies of spinocerebellar ataxia type 3"],"prefix":"10.1515","volume":"26","author":[{"given":"Yan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref1341","first-page":"568","article-title":"de randomized phase clinical trial of lithium carbonate in disease","volume":"29","author":"Saute","year":"2014"},{"key":"ref731","first-page":"226","article-title":"Silencing disease genes in the laboratory and the clinic","author":"Watts","year":"2012","journal-title":"Pathol"},{"key":"ref591","first-page":"187","article-title":"Environmental pharmacological and genetic modulation of the HD phenotype in transgenic mice","author":"Schilling","year":"2004","journal-title":"Neurol"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1093\/hmg\/ddr197","article-title":"- dependent upregulation of superoxide dismutase in response to oxidative stress is impaired in spinocerebellar ataxia type","volume":"20","author":"Araujo","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","article-title":"Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"13","author":"Minamiyama","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref1421","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","article-title":"Chronic treatment with improves balance and coordination in a new mouse model of disease","volume":"17","author":"Silva","year":"2014","journal-title":"Neurotherapeutics"},{"key":"ref1361","first-page":"187","article-title":"Environmental pharmacological and genetic modulation of the HD phenotype in transgenic mice","author":"Schilling","year":"2004","journal-title":"Neurol"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12015-013-9443-6","article-title":"Progress in stem cell therapy for major human neurological disorders","author":"Mart\u00ednez","year":"2013","journal-title":"Stem Cell Rev"},{"key":"ref1101","first-page":"206","article-title":"Patterns of mitochondrial DNA damage in blood and brain tissues of a transgenic mouse model of disease","volume":"11","author":"Kazachkova","year":"2012","journal-title":"Dis"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1093\/hmg\/ddp274","article-title":"dependent phosphorylation determines cellular localization and stability of ataxin","volume":"28","author":"Mueller","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1073\/pnas.0407252102","article-title":"The polyglutamine neurodegenerative protein ataxin regulates aggresome formation","author":"Burnett","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref741","first-page":"87","article-title":"Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of disease","author":"Yu","year":"2009","journal-title":"Neurosci Res"},{"key":"ref21","first-page":"280","article-title":"Identification and functional dissection of localization signals within ataxin","author":"Antony","year":"2009","journal-title":"Dis"},{"key":"ref701","first-page":"1","article-title":"the gene product interacts with the two human homologs of yeast DNA repair protein RAD","volume":"23","author":"Wang","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref1511","first-page":"87","article-title":"Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of disease","author":"Yu","year":"2009","journal-title":"Neurosci Res"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molcel.2011.05.036","article-title":"ataxin coordinately regulate the ubiquitin ligase CHIP","author":"Scaglione","year":"2011","journal-title":"Mol Cell"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3727\/096368914X678454","article-title":"diseases to treatments","volume":"23","author":"Fan","year":"2014","journal-title":"genetics Cell Transplant"},{"key":"ref411","first-page":"1","article-title":"of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type disease patients","author":"Maciel","year":"1997","journal-title":"Am Hum Genet"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2006.07.030","article-title":"pathways modulate polyglutamine - induced","volume":"24","author":"Bilen","year":"2006","journal-title":"neurodegeneration Mol Cell"},{"key":"ref141","first-page":"89","article-title":"- expanded ataxin - causes cerebellar dysfunction of SCA transgenic mice by inducing transcriptional dysregulation","volume":"31","author":"Chou","year":"2008","journal-title":"Dis"},{"key":"ref521","first-page":"18789","article-title":"major role for side - chain polyglutamine hydrogen bonding in irreversible ataxin - aggregation One","author":"Natalello","year":"2011"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1523\/JNEUROSCI.3909-08.2008","article-title":"Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type","volume":"28","author":"Chen","year":"2008","journal-title":"Neurosci"},{"key":"ref1461","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/emboj.2008.289","article-title":"Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin","volume":"28","author":"Todi","year":"2009","journal-title":"EMBO J"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1523\/JNEUROSCI.3909-08.2008","article-title":"Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type","volume":"28","author":"Chen","year":"2008","journal-title":"Neurosci"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1093\/hmg\/ddp456","article-title":"Preventing ataxin protein cleavage mitigates degeneration in a Drosophila model of","volume":"18","author":"Jung","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1523\/JNEUROSCI.23-06-02203.2003","article-title":"Heat shock protein chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear - localized mutant androgen receptor protein","volume":"70","author":"Adachi","year":"2003","journal-title":"J Neurosci"},{"key":"ref41","first-page":"284","article-title":"Inhibition of Rho kinases enhances the degradation of mutant huntingtin","author":"Bauer","year":"2009","journal-title":"Biol Chem"},{"key":"ref371","first-page":"277","article-title":"is a histone - binding protein with two independent transcriptional corepressor activities","author":"Li","year":"2002","journal-title":"Biol Chem"},{"key":"ref761","first-page":"108","article-title":"Zu Non initiated translation directed by microsatellite expansions","author":"Gibbens","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref1481","first-page":"285","article-title":"Six cases of MJD patients that mimic hereditary spastic paraplegia in clinic","author":"Wang","year":"2009","journal-title":"Neurol Sci"},{"key":"ref271","first-page":"392","article-title":"Allele - selective inhibition of ataxin expression by anti - sense oligomers and duplex","author":"Hu","year":"2011","journal-title":"Biol Chem"},{"key":"ref551","first-page":"107","article-title":"heat - shock proteins interact with a flanking domain to suppress polyglutamine aggregation","author":"Robertson","year":"2010","journal-title":"Small Proc Natl Acad Sci USA"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1093\/hmg\/ddp274","article-title":"dependent phosphorylation determines cellular localization and stability of ataxin","volume":"28","author":"Mueller","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate - prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref201","first-page":"24308","article-title":"van den van and Mom Targeting several CAG expansion diseases by a single antisense oligonucleotide One","author":"Evers","year":"2011"},{"key":"ref171","first-page":"11728","article-title":"do plays a role in mouse myogenic differentiation through regulation of integrin subunit levels One","author":"Carmo Costa","year":"2010"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/318184","article-title":"Ancestral origins of the Joseph disease mutation a worldwide haplotype study","author":"Gaspar","year":"2001","journal-title":"Am Hum Genet"},{"key":"ref71","first-page":"285","article-title":"Nuclear aggregation of polyglutamine - expanded ataxin fragments escape the cytoplasmic quality control","author":"Breuer","year":"2010","journal-title":"Biol Chem"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1523\/JNEUROSCI.21-15-05389.2001","article-title":"de and Inflammatory genes are upregulated in expanded ataxin - expressing cell lines and spinocerebellar ataxia type brains","volume":"21","author":"Evert","year":"2011","journal-title":"Neurosci"},{"key":"ref1401","doi-asserted-by":"crossref","first-page":"13002","DOI":"10.1523\/JNEUROSCI.2789-11.2011","article-title":"do and Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type","volume":"31","author":"Shakkottai","year":"2011","journal-title":"Neurosci"},{"key":"ref621","first-page":"139","article-title":"clinical aspects of disease","author":"Sequeiros","year":"1993","journal-title":"Epidemiology Adv Neurol"},{"key":"ref661","first-page":"135","article-title":"de - mediated inhibition of calpains in the mouse brain prevents mutant ataxin proteolysis nuclear localization and aggregation relieving - disease","author":"Sim\u00f5es","year":"2012","journal-title":"Brain"},{"key":"ref111","first-page":"276","article-title":"The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease","author":"Chai","year":"2001","journal-title":"Biol Chem"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.bpj.2011.02.056","article-title":"The Josephin domain determines the morphological and mechanical properties of ataxin - fibrils","author":"Masino","year":"2011","journal-title":"Biophys J"},{"key":"ref301","first-page":"1","article-title":"Intergenerational instability of the CAG repeat of the gene for disease is affected by the genotype of the normal chromosome : implications for the molecular mechanisms of the instability of the CAG repeat","author":"Igarashi","year":"1996","journal-title":"Hum Mol Genet"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.01.006","article-title":"promotes the degradation of polyglutamine - expanded ataxin or ataxin independently of its ROCK - inhibiting effect and ameliorates mutant ataxin - induced neurodegeneration in the SCA transgenic mouse","author":"Wang","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref311","first-page":"899","article-title":"findings in disease relation with disease duration subtypes","author":"Jardim","year":"2001","journal-title":"Arch"},{"key":"ref1271","first-page":"183","article-title":"is recruited selectively to impaired mitochondria and promotes their autophagy","author":"Narendra","year":"2008","journal-title":"Cell Biol"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","article-title":"Chronic treatment with improves balance and coordination in a new mouse model of disease","volume":"17","author":"Silva","year":"2014","journal-title":"Neurotherapeutics"},{"key":"ref841","first-page":"285","article-title":"Nuclear aggregation of polyglutamine - expanded ataxin fragments escape the cytoplasmic quality control","author":"Breuer","year":"2010","journal-title":"Biol Chem"},{"key":"ref1041","first-page":"392","article-title":"Allele - selective inhibition of ataxin expression by anti - sense oligomers and duplex","author":"Hu","year":"2011","journal-title":"Biol Chem"},{"key":"ref1221","first-page":"223","article-title":"stem cell transplantation in amyotrophic lateral sclerosis a phase I clinical trial","author":"Mazzini","year":"2010","journal-title":"Exp Neurol"},{"key":"ref681","first-page":"1","article-title":"specific proteotoxicity of mutant ataxin inC elegans rescue by the DAF pathways","volume":"16","author":"Teixeira","year":"2011","journal-title":"Neuron Hum Mol Genet"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1093\/hmg\/ddg344","article-title":"The polyglutamine neurodegenerative protein ataxin binds polyubiquitylated proteins and has ubiquitin protease activity","volume":"12","author":"Burnett","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/hmg\/ddp482","article-title":"stress increases nuclear localization of ataxin","volume":"19","author":"Reina","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1093\/hmg\/ddp456","article-title":"Preventing ataxin protein cleavage mitigates degeneration in a Drosophila model of","volume":"18","author":"Jung","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/bip.21210","article-title":"Josephin domain of ataxin contains two distinct ubiquitin - binding sites","author":"Nicastro","year":"2009","journal-title":"Biopolymers"},{"key":"ref1321","first-page":"107","article-title":"heat - shock proteins interact with a flanking domain to suppress polyglutamine aggregation","author":"Robertson","year":"2010","journal-title":"Small Proc Natl Acad Sci USA"},{"key":"ref151","first-page":"378","article-title":"skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment : an open - label phase dose - escalation study","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"ref671","first-page":"69","article-title":"Early or late - stage anti terminal Huntingtin intrabody gene therapy reduces pathological features in mice","volume":"6","author":"Snyder","year":"2010","journal-title":"Neurol"},{"key":"ref971","first-page":"24308","article-title":"van den van and Mom Targeting several CAG expansion diseases by a single antisense oligonucleotide One","author":"Evers","year":"2011"},{"key":"ref1281","first-page":"1","article-title":"of the autophagic beclin protein clears mutant ataxin alleviates disease","author":"Nascimento","year":"2011","journal-title":"Brain"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.bpj.2011.02.056","article-title":"The Josephin domain determines the morphological and mechanical properties of ataxin - fibrils","author":"Masino","year":"2011","journal-title":"Biophys J"},{"key":"ref211","first-page":"49","article-title":"den van and protein modification as a treatment strategy for spinocerebellar ataxia type removal of the CAG containing exon","volume":"58","author":"Evers","year":"2013","journal-title":"Dis"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1523\/JNEUROSCI.19-23-10338.1999","article-title":"of the role of heat shock protein molecular chaperones in polyglutamine disease","volume":"19","author":"Chai","year":"1999","journal-title":"Analysis Neurosci"},{"key":"ref1491","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.01.006","article-title":"promotes the degradation of polyglutamine - expanded ataxin or ataxin independently of its ROCK - inhibiting effect and ameliorates mutant ataxin - induced neurodegeneration in the SCA transgenic mouse","author":"Wang","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref1521","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/hmg\/ddl164","article-title":"binds regulates retrotranslocation of substrates","volume":"15","author":"Zhong","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref331","first-page":"206","article-title":"Patterns of mitochondrial DNA damage in blood and brain tissues of a transgenic mouse model of disease","volume":"11","author":"Kazachkova","year":"2012","journal-title":"Dis"},{"key":"ref981","first-page":"49","article-title":"den van and protein modification as a treatment strategy for spinocerebellar ataxia type removal of the CAG containing exon","volume":"58","author":"Evers","year":"2013","journal-title":"Dis"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/318184","article-title":"Ancestral origins of the Joseph disease mutation a worldwide haplotype study","author":"Gaspar","year":"2001","journal-title":"Am Hum Genet"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/hmg\/ddq452","article-title":"The Joseph disease - associated mutant form of ataxin regulates parkin ubiquitination and stability","volume":"20","author":"Durcan","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref1391","first-page":"139","article-title":"clinical aspects of disease","author":"Sequeiros","year":"1993","journal-title":"Epidemiology Adv Neurol"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington s disease by transient repression of huntingtin synthesis","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"ref1451","first-page":"1","article-title":"specific proteotoxicity of mutant ataxin inC elegans rescue by the DAF pathways","volume":"16","author":"Teixeira","year":"2011","journal-title":"Neuron Hum Mol Genet"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s100380170060","article-title":"The genomic structure and expression of the disease gene","author":"Ichikawa","year":"2001","journal-title":"Hum Genet"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"in Huntington disease is safe tolerable bioavailable in brain and reduces serum OH dG","volume":"8","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"ref1351","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molcel.2011.05.036","article-title":"ataxin coordinately regulate the ubiquitin ligase CHIP","author":"Scaglione","year":"2011","journal-title":"Mol Cell"},{"key":"ref911","first-page":"89","article-title":"- expanded ataxin - causes cerebellar dysfunction of SCA transgenic mice by inducing transcriptional dysregulation","volume":"31","author":"Chou","year":"2008","journal-title":"Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"de Silencing ataxin mitigates degeneration in a rat model of disease no role for wild - type ataxin","volume":"19","author":"Alves","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref1471","first-page":"1","article-title":"the gene product interacts with the two human homologs of yeast DNA repair protein RAD","volume":"23","author":"Wang","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington s disease by transient repression of huntingtin synthesis","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"ref511","first-page":"1","article-title":"of the autophagic beclin protein clears mutant ataxin alleviates disease","author":"Nascimento","year":"2011","journal-title":"Brain"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD delivered intrathecally for patients with SOD familial amyotrophic lateral sclerosis : a phase randomised first - in - man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1523\/JNEUROSCI.19-23-10338.1999","article-title":"of the role of heat shock protein molecular chaperones in polyglutamine disease","volume":"19","author":"Chai","year":"1999","journal-title":"Analysis Neurosci"},{"key":"ref791","first-page":"280","article-title":"Identification and functional dissection of localization signals within ataxin","author":"Antony","year":"2009","journal-title":"Dis"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD delivered intrathecally for patients with SOD familial amyotrophic lateral sclerosis : a phase randomised first - in - man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol"},{"key":"ref1381","first-page":"120","article-title":"den de and inclusions in spinocerebellar ataxia type","author":"Seidel","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3727\/096368914X678454","article-title":"diseases to treatments","volume":"23","author":"Fan","year":"2014","journal-title":"genetics Cell Transplant"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1523\/JNEUROSCI.23-06-02203.2003","article-title":"Heat shock protein chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear - localized mutant androgen receptor protein","volume":"70","author":"Adachi","year":"2003","journal-title":"J Neurosci"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/emboj.2008.289","article-title":"Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin","volume":"28","author":"Todi","year":"2009","journal-title":"EMBO J"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","article-title":"Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"13","author":"Minamiyama","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1093\/nar\/gkt594","article-title":"a duplexes with abasic substitutions are potent and allele - selective inhibitors of huntingtin and ataxin expression","author":"Liu","year":"2013","journal-title":"RNA Nucleic Acids Res"},{"key":"ref1131","first-page":"240","article-title":"The leucine zipper : a hypothetical structure common to a new class of DNA binding proteins","author":"Landschulz","year":"1988","journal-title":"Science"},{"key":"ref1291","first-page":"18789","article-title":"major role for side - chain polyglutamine hydrogen bonding in irreversible ataxin - aggregation One","author":"Natalello","year":"2011"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"13002","DOI":"10.1523\/JNEUROSCI.2789-11.2011","article-title":"do and Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type","volume":"31","author":"Shakkottai","year":"2011","journal-title":"Neurosci"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12015-013-9443-6","article-title":"Progress in stem cell therapy for major human neurological disorders","author":"Mart\u00ednez","year":"2013","journal-title":"Stem Cell Rev"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","article-title":"dominant cerebellar ataxias polyglutamine expansions and beyond","author":"Durr","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref1441","first-page":"69","article-title":"Early or late - stage anti terminal Huntingtin intrabody gene therapy reduces pathological features in mice","volume":"6","author":"Snyder","year":"2010","journal-title":"Neurol"},{"key":"ref361","first-page":"240","article-title":"The leucine zipper : a hypothetical structure common to a new class of DNA binding proteins","author":"Landschulz","year":"1988","journal-title":"Science"},{"key":"ref641","first-page":"163","article-title":"Motor uncoordination and neuropathology in a transgenic mouse model of Joseph disease lacking intranuclear inclusions and ataxin cleavage products","author":"Silva","year":"2010","journal-title":"Dis"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1093\/nar\/gkt594","article-title":"a duplexes with abasic substitutions are potent and allele - selective inhibitors of huntingtin and ataxin expression","author":"Liu","year":"2013","journal-title":"RNA Nucleic Acids Res"},{"key":"ref1211","first-page":"549","article-title":"Domain architecture of the polyglutamine protein ataxin a globular domain followed by a flexible tail","author":"Masino","year":"2013","journal-title":"FEBS Lett"},{"key":"ref1141","first-page":"277","article-title":"is a histone - binding protein with two independent transcriptional corepressor activities","author":"Li","year":"2002","journal-title":"Biol Chem"},{"key":"ref221","first-page":"1006","article-title":"de and Gene expression profiling in ataxin expressing cell lines reveals distinct effects of normal and mutant ataxin","author":"Evert","year":"2003","journal-title":"Neurol"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"in Huntington disease is safe tolerable bioavailable in brain and reduces serum OH dG","volume":"8","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"ref1231","first-page":"133","article-title":"induction reduces mutant ataxin - levels and toxicity in a mouse model of spinocerebellar ataxia type","author":"Menzies","year":"2010","journal-title":"Autophagy Brain"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","article-title":"dominant cerebellar ataxias polyglutamine expansions and beyond","author":"Durr","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1073\/pnas.0407252102","article-title":"The polyglutamine neurodegenerative protein ataxin regulates aggresome formation","author":"Burnett","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1523\/JNEUROSCI.21-15-05389.2001","article-title":"de and Inflammatory genes are upregulated in expanded ataxin - expressing cell lines and spinocerebellar ataxia type brains","volume":"21","author":"Evert","year":"2011","journal-title":"Neurosci"},{"key":"ref931","first-page":"104","article-title":"suppresses polyglutamine - induced degeneration post onset in aDrosophilaMJD model","author":"Cushman","year":"2013","journal-title":"PLoS Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1093\/hmg\/ddr197","article-title":"- dependent upregulation of superoxide dismutase in response to oxidative stress is impaired in spinocerebellar ataxia type","volume":"20","author":"Araujo","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref1501","first-page":"226","article-title":"Silencing disease genes in the laboratory and the clinic","author":"Watts","year":"2012","journal-title":"Pathol"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate - prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref1431","first-page":"135","article-title":"de - mediated inhibition of calpains in the mouse brain prevents mutant ataxin proteolysis nuclear localization and aggregation relieving - disease","author":"Sim\u00f5es","year":"2012","journal-title":"Brain"},{"key":"ref1531","first-page":"108","article-title":"Zu Non initiated translation directed by microsatellite expansions","author":"Gibbens","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/hmg\/ddq452","article-title":"The Joseph disease - associated mutant form of ataxin regulates parkin ubiquitination and stability","volume":"20","author":"Durcan","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref161","first-page":"104","article-title":"suppresses polyglutamine - induced degeneration post onset in aDrosophilaMJD model","author":"Cushman","year":"2013","journal-title":"PLoS Genet"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/hmg\/ddl164","article-title":"binds regulates retrotranslocation of substrates","volume":"15","author":"Zhong","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref1111","first-page":"480","article-title":"Excitation - induced ataxin aggregation in neurons from patients with disease","author":"Koch","year":"2011","journal-title":"Nature"},{"key":"ref1331","first-page":"193","article-title":"disease an autosomal dominant motor system degeneration","author":"Rosenberg","year":"1992"},{"key":"ref1071","first-page":"1","article-title":"Intergenerational instability of the CAG repeat of the gene for disease is affected by the genotype of the normal chromosome : implications for the molecular mechanisms of the instability of the CAG repeat","author":"Igarashi","year":"1996","journal-title":"Hum Mol Genet"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1093\/hmg\/ddg344","article-title":"The polyglutamine neurodegenerative protein ataxin binds polyubiquitylated proteins and has ubiquitin protease activity","volume":"12","author":"Burnett","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref941","first-page":"11728","article-title":"do plays a role in mouse myogenic differentiation through regulation of integrin subunit levels One","author":"Carmo Costa","year":"2010"},{"key":"ref881","first-page":"276","article-title":"The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease","author":"Chai","year":"2001","journal-title":"Biol Chem"},{"key":"ref921","first-page":"378","article-title":"skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment : an open - label phase dose - escalation study","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"ref811","first-page":"284","article-title":"Inhibition of Rho kinases enhances the degradation of mutant huntingtin","author":"Bauer","year":"2009","journal-title":"Biol Chem"},{"key":"ref991","first-page":"1006","article-title":"de and Gene expression profiling in ataxin expressing cell lines reveals distinct effects of normal and mutant ataxin","author":"Evert","year":"2003","journal-title":"Neurol"},{"key":"ref461","first-page":"133","article-title":"induction reduces mutant ataxin - levels and toxicity in a mouse model of spinocerebellar ataxia type","author":"Menzies","year":"2010","journal-title":"Autophagy Brain"},{"key":"ref341","first-page":"480","article-title":"Excitation - induced ataxin aggregation in neurons from patients with disease","author":"Koch","year":"2011","journal-title":"Nature"},{"key":"ref1181","first-page":"1","article-title":"of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type disease patients","author":"Maciel","year":"1997","journal-title":"Am Hum Genet"},{"key":"ref441","first-page":"549","article-title":"Domain architecture of the polyglutamine protein ataxin a globular domain followed by a flexible tail","author":"Masino","year":"2013","journal-title":"FEBS Lett"},{"key":"ref891","first-page":"454","article-title":"Decreased protein synthesis of associated with cellular toxicity in a cell model of disease","volume":"27","author":"Chang","year":"2009","journal-title":"Neurosci Lett"},{"key":"ref571","first-page":"568","article-title":"de randomized phase clinical trial of lithium carbonate in disease","volume":"29","author":"Saute","year":"2014"},{"key":"ref121","first-page":"454","article-title":"Decreased protein synthesis of associated with cellular toxicity in a cell model of disease","volume":"27","author":"Chang","year":"2009","journal-title":"Neurosci Lett"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/hmg\/ddp482","article-title":"stress increases nuclear localization of ataxin","volume":"19","author":"Reina","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s100380170060","article-title":"The genomic structure and expression of the disease gene","author":"Ichikawa","year":"2001","journal-title":"Hum Genet"},{"key":"ref1411","first-page":"163","article-title":"Motor uncoordination and neuropathology in a transgenic mouse model of Joseph disease lacking intranuclear inclusions and ataxin cleavage products","author":"Silva","year":"2010","journal-title":"Dis"},{"key":"ref501","first-page":"183","article-title":"is recruited selectively to impaired mitochondria and promotes their autophagy","author":"Narendra","year":"2008","journal-title":"Cell Biol"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"de Silencing ataxin mitigates degeneration in a rat model of disease no role for wild - type ataxin","volume":"19","author":"Alves","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref711","first-page":"285","article-title":"Six cases of MJD patients that mimic hereditary spastic paraplegia in clinic","author":"Wang","year":"2009","journal-title":"Neurol Sci"},{"key":"ref611","first-page":"120","article-title":"den de and inclusions in spinocerebellar ataxia type","author":"Seidel","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2006.07.030","article-title":"pathways modulate polyglutamine - induced","volume":"24","author":"Bilen","year":"2006","journal-title":"neurodegeneration Mol Cell"},{"key":"ref451","first-page":"223","article-title":"stem cell transplantation in amyotrophic lateral sclerosis a phase I clinical trial","author":"Mazzini","year":"2010","journal-title":"Exp Neurol"},{"key":"ref561","first-page":"193","article-title":"disease an autosomal dominant motor system degeneration","author":"Rosenberg","year":"1992"},{"key":"ref1081","first-page":"899","article-title":"findings in disease relation with disease duration subtypes","author":"Jardim","year":"2001","journal-title":"Arch"},{"key":"ref1301","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/bip.21210","article-title":"Josephin domain of ataxin contains two distinct ubiquitin - binding sites","author":"Nicastro","year":"2009","journal-title":"Biopolymers"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2014-0040\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T03:57:19Z","timestamp":1619063839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2014-0040\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":146,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1515\/revneuro-2014-0040","relation":{},"ISSN":["2191-0200","0334-1763"],"issn-type":[{"value":"2191-0200","type":"electronic"},{"value":"0334-1763","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,1]]}}}